ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Proteins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-34G8837
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Proteins Market Size Status and Forecast 2022
BUY CHAPTERS

Global Recombinant Proteins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-34G8837
Report
June 2025
Pages:143
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abcam
Miltenyi Biotec
Thermo Fisher Scientific
Merck KGaA
Prospec-Tany Technogene
BPS Bioscience
Reprocell
Genscript Biotech Corporation
Abnova Corporation
Bio Techne Corporation
ACROBiosystems
Sino Biological
Cytiva
Eurogentec S.A
Ajinomoto

Recombinant Proteins Market Size

In 2024, the global market size of Recombinant Proteins was estimated to be worth US$ 1244 million and is forecast to reach approximately US$ 2896 million by 2031 with a CAGR of 13.0% during the forecast period 2025-2031.

Recombinant Proteins Market

Recombinant Proteins Market

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Proteins.
The Recombinant Proteins market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Proteins companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Recombinant Proteins Market Report

Report Metric Details
Report Name Recombinant Proteins Market
Forecasted market size in 2031 approximately US$ 2896 million
CAGR 13.0%
Forecasted years 2025 - 2031
Segment by Type
  • Hormones
  • Growth Factors
  • Cytokines
  • Plasma Protein Factor
  • Recombinant Metabolic Enzymes
  • Immune Checkpoint Regulators
  • Others
Segment by Application
  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • Contract Research Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Recombinant Proteins in global and regional level.
  • Chapter 3: Detailed analysis of Recombinant Proteins company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Proteins revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Recombinant Proteins Market size in 2031?

Ans: The Recombinant Proteins Market size in 2031 will be approximately US$ 2896 million.

What is the market share of major companies in Recombinant Proteins Market?

Ans: The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%.

What is the Recombinant Proteins Market share by region?

Ans: In terms of market size, Asia Pacific is the largest consumption market with more than 35% share.

What is the Recombinant Proteins Market share by type?

Ans: In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively.

Who are the main players in the Recombinant Proteins Market report?

Ans: The main players in the Recombinant Proteins Market are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, Cytiva, Eurogentec, GenScript Biotech Corporation, Reprocell, BPS Bioscience, Abnova Corporation, ProSpec Tany TechnoGene, Ajinomoto

What are the Application segmentation covered in the Recombinant Proteins Market report?

Ans: The Applications covered in the Recombinant Proteins Market report are Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations

What are the Type segmentation covered in the Recombinant Proteins Market report?

Ans: The Types covered in the Recombinant Proteins Market report are Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, Others

1 Study Coverage
1.1 Recombinant Proteins Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Proteins Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Hormones
1.2.3 Growth Factors
1.2.4 Cytokines
1.2.5 Plasma Protein Factor
1.2.6 Recombinant Metabolic Enzymes
1.2.7 Immune Checkpoint Regulators
1.2.8 Others
1.3 Market by Application
1.3.1 Global Recombinant Proteins Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.3.4 Contract Research Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant Proteins Market Size Estimates and Forecasts
2.2 Recombinant Proteins Market Size by Region: 2024 Versus 2031
2.2.1 Global Recombinant Proteins Revenue by Region: 2020-2025
2.2.2 Global Recombinant Proteins Revenue Forecast by Region (2026-2031)
2.2.3 Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Recombinant Proteins Revenue by Type (2020-2031)
3.1.2 Global Recombinant Proteins Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Recombinant Proteins Revenue by Application (2020-2031)
3.2.2 Global Recombinant Proteins Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Hormones of Recombinant Proteins Revenue Market Share by Application
3.3.2 Growth Factors of Recombinant Proteins Revenue Market Share by Application
3.3.3 Cytokines of Recombinant Proteins Revenue Market Share by Application
3.3.4 Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application
3.3.5 Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application
3.3.6 Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application
3.3.7 Others of Recombinant Proteins Revenue Market Share by Application
4 Global Recombinant Proteins by Company
4.1 Global Recombinant Proteins Revenue by Company (2020-2025)
4.2 Global Recombinant Proteins Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Recombinant Proteins Companies around the World: Ranking by Revenue
4.3.2 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Recombinant Proteins Companies Headquarters & Product Type
4.4.1 Global Recombinant Proteins Companies Headquarters
4.4.2 Date of International Companies Enter into Recombinant Proteins Market
4.4.3 Global Recombinant Proteins Companies Product & Service
4.4.4 Hormones Revenue Market Share of Recombinant Proteins by Company
4.4.5 Growth Factors Revenue Market Share of Recombinant Proteins by Company
4.4.6 Cytokines Revenue Market Share of Recombinant Proteins by Company
4.4.7 Plasma Protein Factor Revenue Market Share of Recombinant Proteins by Company
4.4.8 Recombinant Metabolic Enzymes Revenue Market Share of Recombinant Proteins by Company
4.4.9 Immune Checkpoint Regulators Revenue Market Share of Recombinant Proteins by Company
4.4.10 Others Revenue Market Share of Recombinant Proteins by Company
4.5 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bio-Techne Corporation
5.1.1 Bio-Techne Corporation Corporation Information
5.1.2 Bio-Techne Corporation Description, Business Overview
5.1.3 Bio-Techne Corporation Recombinant Proteins Products Offered
5.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.1.5 Bio-Techne Corporation Recombinant Proteins Revenue by Product in 2024
5.1.6 Bio-Techne Corporation Recombinant Proteins Revenue by Application in 2024
5.1.7 Bio-Techne Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.1.8 Bio-Techne Corporation Recent Developments
5.2 Abcam PLC
5.2.1 Abcam PLC Corporation Information
5.2.2 Abcam PLC Description, Business Overview
5.2.3 Abcam PLC Recombinant Proteins Products Offered
5.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.2.5 Abcam PLC Recombinant Proteins Revenue by Product in 2024
5.2.6 Abcam PLC Recombinant Proteins Revenue by Application in 2024
5.2.7 Abcam PLC Recombinant Proteins Revenue by Geographic Area in 2024
5.2.8 Abcam PLC Recent Developments
5.3 Merck KGaA
5.3.1 Merck KGaA Corporation Information
5.3.2 Merck KGaA Description, Business Overview
5.3.3 Merck KGaA Recombinant Proteins Products Offered
5.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.3.5 Merck KGaA Recombinant Proteins Revenue by Product in 2024
5.3.6 Merck KGaA Recombinant Proteins Revenue by Application in 2024
5.3.7 Merck KGaA Recombinant Proteins Revenue by Geographic Area in 2024
5.3.8 Merck KGaA Recent Developments
5.4 Miltenyi Biotec
5.4.1 Miltenyi Biotec Corporation Information
5.4.2 Miltenyi Biotec Description, Business Overview
5.4.3 Miltenyi Biotec Recombinant Proteins Products Offered
5.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.4.5 Miltenyi Biotec Recombinant Proteins Revenue by Product in 2024
5.4.6 Miltenyi Biotec Recombinant Proteins Revenue by Application in 2024
5.4.7 Miltenyi Biotec Recombinant Proteins Revenue by Geographic Area in 2024
5.4.8 Miltenyi Biotec Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Corporation Information
5.5.2 Thermo Fisher Scientific Description, Business Overview
5.5.3 Thermo Fisher Scientific Recombinant Proteins Products Offered
5.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.5.5 Thermo Fisher Scientific Recombinant Proteins Revenue by Product in 2024
5.5.6 Thermo Fisher Scientific Recombinant Proteins Revenue by Application in 2024
5.5.7 Thermo Fisher Scientific Recombinant Proteins Revenue by Geographic Area in 2024
5.5.8 Thermo Fisher Scientific Recent Developments
5.6 ACROBiosystems
5.6.1 ACROBiosystems Corporation Information
5.6.2 ACROBiosystems Description, Business Overview
5.6.3 ACROBiosystems Recombinant Proteins Products Offered
5.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.6.5 ACROBiosystems Recombinant Proteins Revenue by Product in 2024
5.6.6 ACROBiosystems Recombinant Proteins Revenue by Application in 2024
5.6.7 ACROBiosystems Recombinant Proteins Revenue by Geographic Area in 2024
5.6.8 ACROBiosystems Recent Developments
5.7 Sino Biological
5.7.1 Sino Biological Corporation Information
5.7.2 Sino Biological Description, Business Overview
5.7.3 Sino Biological Recombinant Proteins Products Offered
5.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.7.5 Sino Biological Recombinant Proteins Revenue by Product in 2024
5.7.6 Sino Biological Recombinant Proteins Revenue by Application in 2024
5.7.7 Sino Biological Recombinant Proteins Revenue by Geographic Area in 2024
5.7.8 Sino Biological Recent Developments
5.8 Cytiva
5.8.1 Cytiva Corporation Information
5.8.2 Cytiva Description, Business Overview
5.8.3 Cytiva Recombinant Proteins Products Offered
5.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.8.5 Cytiva Recombinant Proteins Revenue by Product in 2024
5.8.6 Cytiva Recombinant Proteins Revenue by Application in 2024
5.8.7 Cytiva Recombinant Proteins Revenue by Geographic Area in 2024
5.8.8 Cytiva Recent Developments
5.9 Eurogentec
5.9.1 Eurogentec Corporation Information
5.9.2 Eurogentec Description, Business Overview
5.9.3 Eurogentec Recombinant Proteins Products Offered
5.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.9.5 Eurogentec Recombinant Proteins Revenue by Product in 2024
5.9.6 Eurogentec Recombinant Proteins Revenue by Application in 2024
5.9.7 Eurogentec Recombinant Proteins Revenue by Geographic Area in 2024
5.9.8 Eurogentec Recent Developments
5.10 GenScript Biotech Corporation
5.10.1 GenScript Biotech Corporation Corporation Information
5.10.2 GenScript Biotech Corporation Description, Business Overview
5.10.3 GenScript Biotech Corporation Recombinant Proteins Products Offered
5.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.10.5 GenScript Biotech Corporation Recombinant Proteins Revenue by Product in 2024
5.10.6 GenScript Biotech Corporation Recombinant Proteins Revenue by Application in 2024
5.10.7 GenScript Biotech Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.10.8 GenScript Biotech Corporation Recent Developments
5.11 Reprocell
5.11.1 Reprocell Corporation Information
5.11.2 Reprocell Description, Business Overview
5.11.3 Reprocell Recombinant Proteins Products Offered
5.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.11.5 Reprocell Recombinant Proteins Revenue by Product in 2024
5.11.6 Reprocell Recombinant Proteins Revenue by Application in 2024
5.11.7 Reprocell Recombinant Proteins Revenue by Geographic Area in 2024
5.11.8 Reprocell Recent Developments
5.12 BPS Bioscience
5.12.1 BPS Bioscience Corporation Information
5.12.2 BPS Bioscience Description, Business Overview
5.12.3 BPS Bioscience Recombinant Proteins Products Offered
5.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.12.5 BPS Bioscience Recombinant Proteins Revenue by Product in 2024
5.12.6 BPS Bioscience Recombinant Proteins Revenue by Application in 2024
5.12.7 BPS Bioscience Recombinant Proteins Revenue by Geographic Area in 2024
5.12.8 BPS Bioscience Recent Developments
5.13 Abnova Corporation
5.13.1 Abnova Corporation Corporation Information
5.13.2 Abnova Corporation Description, Business Overview
5.13.3 Abnova Corporation Recombinant Proteins Products Offered
5.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.13.5 Abnova Corporation Recombinant Proteins Revenue by Product in 2024
5.13.6 Abnova Corporation Recombinant Proteins Revenue by Application in 2024
5.13.7 Abnova Corporation Recombinant Proteins Revenue by Geographic Area in 2024
5.13.8 Abnova Corporation Recent Developments
5.14 ProSpec Tany TechnoGene
5.14.1 ProSpec Tany TechnoGene Corporation Information
5.14.2 ProSpec Tany TechnoGene Description, Business Overview
5.14.3 ProSpec Tany TechnoGene Recombinant Proteins Products Offered
5.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.14.5 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Product in 2024
5.14.6 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Application in 2024
5.14.7 ProSpec Tany TechnoGene Recombinant Proteins Revenue by Geographic Area in 2024
5.14.8 ProSpec Tany TechnoGene Recent Developments
5.15 Ajinomoto
5.15.1 Ajinomoto Corporation Information
5.15.2 Ajinomoto Description, Business Overview
5.15.3 Ajinomoto Recombinant Proteins Products Offered
5.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin (2020-2025)
5.15.5 Ajinomoto Recombinant Proteins Revenue by Product in 2024
5.15.6 Ajinomoto Recombinant Proteins Revenue by Application in 2024
5.15.7 Ajinomoto Recombinant Proteins Revenue by Geographic Area in 2024
5.15.8 Ajinomoto Recent Developments
6 North America
6.1 North America Recombinant Proteins Market Size YoY Growth 2020-2031
6.2 North America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
6.3 North America Recombinant Proteins Revenue by Type (2020-2025)
6.4 North America Recombinant Proteins Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Recombinant Proteins Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Recombinant Proteins Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025)
7.4 Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025)
8 Europe
8.1 Europe Recombinant Proteins Market Size YoY Growth 2020-2031
8.2 Europe Recombinant Proteins Market Facts & Figures by Country (2020-2031)
8.3 Europe Recombinant Proteins Revenue by Type (2020-2025)
8.4 Europe Recombinant Proteins Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
9.2 Latin America Recombinant Proteins Market Facts & Figures by Country (2020-2031)
9.3 Latin America Recombinant Proteins Revenue by Type (2020-2025)
9.4 Latin America Recombinant Proteins Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Recombinant Proteins Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Recombinant Proteins Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025)
10.4 Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Recombinant Proteins Supply Chain Analysis
11.2 Recombinant Proteins Key Raw Materials and Upstream Suppliers
11.3 Recombinant Proteins Clients Analysis
11.4 Recombinant Proteins Sales Channel and Sales Model Analysis
11.4.1 Recombinant Proteins Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Recombinant Proteins Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Recombinant Proteins Distributors
12 Recombinant Proteins Market Dynamics
12.1 Recombinant Proteins Industry Trends
12.2 Recombinant Proteins Market Drivers
12.3 Recombinant Proteins Market Challenges
12.4 Recombinant Proteins Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Abcam
Miltenyi Biotec
Thermo Fisher Scientific
Merck KGaA
Prospec-Tany Technogene
BPS Bioscience
Reprocell
Genscript Biotech Corporation
Abnova Corporation
Bio Techne Corporation
ACROBiosystems
Sino Biological
Cytiva
Eurogentec S.A
Ajinomoto
List of Tables
 Table 1. Global Recombinant Proteins Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Recombinant Proteins Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Recombinant Proteins Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Recombinant Proteins Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Recombinant Proteins Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Recombinant Proteins Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Recombinant Proteins Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Recombinant Proteins Players by Revenue (US$ Million) in 2024
 Table 13. Global Recombinant Proteins Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Recombinant Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Proteins as of 2024)
 Table 15. Global Recombinant Proteins Companies Headquarters
 Table 16. Date of International Companies Enter into Recombinant Proteins Market
 Table 17. Global Recombinant Proteins Companies Product & Service
 Table 18. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
 Table 19. Bio-Techne Corporation Corporation Information
 Table 20. Bio-Techne Corporation Description and Business Overview
 Table 21. Bio-Techne Corporation Recombinant Proteins Product
 Table 22. Bio-Techne Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 24. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 25. Bio-Techne Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 26. Bio-Techne Corporation Recent Developments
 Table 27. Abcam PLC Corporation Information
 Table 28. Abcam PLC Description and Business Overview
 Table 29. Abcam PLC Recombinant Proteins Product
 Table 30. Abcam PLC Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Abcam PLC Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 32. Abcam PLC Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 33. Abcam PLC Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 34. Abcam PLC Recent Developments
 Table 35. Merck KGaA Corporation Information
 Table 36. Merck KGaA Description and Business Overview
 Table 37. Merck KGaA Recombinant Proteins Product
 Table 38. Merck KGaA Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Merck KGaA Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 40. Merck KGaA Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 41. Merck KGaA Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 42. Merck KGaA Recent Developments
 Table 43. Miltenyi Biotec Corporation Information
 Table 44. Miltenyi Biotec Description and Business Overview
 Table 45. Miltenyi Biotec Recombinant Proteins Product
 Table 46. Miltenyi Biotec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 48. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 49. Miltenyi Biotec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 50. Miltenyi Biotec Recent Developments
 Table 51. Thermo Fisher Scientific Corporation Information
 Table 52. Thermo Fisher Scientific Description and Business Overview
 Table 53. Thermo Fisher Scientific Recombinant Proteins Product
 Table 54. Thermo Fisher Scientific Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 56. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 57. Thermo Fisher Scientific Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 58. Thermo Fisher Scientific Recent Developments
 Table 59. ACROBiosystems Corporation Information
 Table 60. ACROBiosystems Description and Business Overview
 Table 61. ACROBiosystems Recombinant Proteins Product
 Table 62. ACROBiosystems Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. ACROBiosystems Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 64. ACROBiosystems Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 65. ACROBiosystems Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 66. ACROBiosystems Recent Developments
 Table 67. Sino Biological Corporation Information
 Table 68. Sino Biological Description and Business Overview
 Table 69. Sino Biological Recombinant Proteins Product
 Table 70. Sino Biological Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Sino Biological Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 72. Sino Biological Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 73. Sino Biological Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 74. Sino Biological Recent Developments
 Table 75. Cytiva Corporation Information
 Table 76. Cytiva Description and Business Overview
 Table 77. Cytiva Recombinant Proteins Product
 Table 78. Cytiva Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Cytiva Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 80. Cytiva Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 81. Cytiva Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 82. Cytiva Recent Developments
 Table 83. Eurogentec Corporation Information
 Table 84. Eurogentec Description and Business Overview
 Table 85. Eurogentec Recombinant Proteins Product
 Table 86. Eurogentec Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Eurogentec Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 88. Eurogentec Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 89. Eurogentec Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 90. Eurogentec Recent Developments
 Table 91. GenScript Biotech Corporation Corporation Information
 Table 92. GenScript Biotech Corporation Description and Business Overview
 Table 93. GenScript Biotech Corporation Recombinant Proteins Product
 Table 94. GenScript Biotech Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 96. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 97. GenScript Biotech Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 98. GenScript Biotech Corporation Recent Developments
 Table 99. Reprocell Corporation Information
 Table 100. Reprocell Description and Business Overview
 Table 101. Reprocell Recombinant Proteins Product
 Table 102. Reprocell Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Reprocell Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 104. Reprocell Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 105. Reprocell Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 106. Reprocell Recent Developments
 Table 107. BPS Bioscience Corporation Information
 Table 108. BPS Bioscience Description and Business Overview
 Table 109. BPS Bioscience Recombinant Proteins Product
 Table 110. BPS Bioscience Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. BPS Bioscience Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 112. BPS Bioscience Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 113. BPS Bioscience Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 114. BPS Bioscience Recent Developments
 Table 115. Abnova Corporation Corporation Information
 Table 116. Abnova Corporation Description and Business Overview
 Table 117. Abnova Corporation Recombinant Proteins Product
 Table 118. Abnova Corporation Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. Abnova Corporation Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 120. Abnova Corporation Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 121. Abnova Corporation Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 122. Abnova Corporation Recent Developments
 Table 123. ProSpec Tany TechnoGene Corporation Information
 Table 124. ProSpec Tany TechnoGene Description and Business Overview
 Table 125. ProSpec Tany TechnoGene Recombinant Proteins Product
 Table 126. ProSpec Tany TechnoGene Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 128. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 129. ProSpec Tany TechnoGene Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 130. ProSpec Tany TechnoGene Recent Developments
 Table 131. Ajinomoto Corporation Information
 Table 132. Ajinomoto Description and Business Overview
 Table 133. Ajinomoto Recombinant Proteins Product
 Table 134. Ajinomoto Recombinant Proteins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Ajinomoto Revenue Proportion of Recombinant Proteins by Product in 2024
 Table 136. Ajinomoto Revenue Proportion of Recombinant Proteins by Application in 2024
 Table 137. Ajinomoto Revenue Proportion of Recombinant Proteins by Geographic Area in 2024
 Table 138. Ajinomoto Recent Developments
 Table 139. North America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
 Table 140. North America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
 Table 141. North America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 142. North America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 143. Asia-Pacific Recombinant Proteins Revenue by Region (2020-2025) & (US$ Million)
 Table 144. Asia-Pacific Recombinant Proteins Revenue by Region (2026-2031) & (US$ Million)
 Table 145. Asia-Pacific Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 146. Asia-Pacific Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 147. Europe Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
 Table 148. Europe Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
 Table 149. Europe Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 150. Europe Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 151. Latin America Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
 Table 152. Latin America Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
 Table 153. Latin America Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 154. Latin America Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 155. Middle East and Africa Recombinant Proteins Revenue by Country (2020-2025) & (US$ Million)
 Table 156. Middle East and Africa Recombinant Proteins Revenue by Country (2026-2031) & (US$ Million)
 Table 157. Middle East and Africa Recombinant Proteins Revenue by Type (2020-2025) & (US$ Million)
 Table 158. Middle East and Africa Recombinant Proteins Revenue by Application (2020-2025) & (US$ Million)
 Table 159. Recombinant Proteins Key Raw Materials, Industry Status and Trend
 Table 160. Recombinant Proteins Key Raw Materials and Upstream Suppliers
 Table 161. Recombinant Proteins Clients Status and Trend
 Table 162. Recombinant Proteins Typical Clients
 Table 163. Recombinant Proteins Distributors
 Table 164. Recombinant Proteins Market Trends
 Table 165. Recombinant Proteins Market Drivers
 Table 166. Recombinant Proteins Market Challenges
 Table 167. Recombinant Proteins Market Restraints
 Table 168. Research Programs/Design for This Report
 Table 169. Key Data Information from Secondary Sources
 Table 170. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Proteins Product Picture
 Figure 2. Global Recombinant Proteins Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Recombinant Proteins Revenue Market Share by Type in 2024 & 2031
 Figure 4. Hormones Product Picture
 Figure 5. Growth Factors Product Picture
 Figure 6. Cytokines Product Picture
 Figure 7. Plasma Protein Factor Product Picture
 Figure 8. Recombinant Metabolic Enzymes Product Picture
 Figure 9. Immune Checkpoint Regulators Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Recombinant Proteins Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Proteins Revenue Market Share by Application in 2024 & 2031
 Figure 13. Biopharmaceutical Companies
 Figure 14. Academic and Research Institutes
 Figure 15. Contract Research Organizations
 Figure 16. Recombinant Proteins Report Years Considered
 Figure 17. Global Recombinant Proteins Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Recombinant Proteins Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Recombinant Proteins Market Size Market Share by Region: 2024 Versus 2031
 Figure 20. Global Recombinant Proteins Revenue Market Share by Region (2020-2031)
 Figure 21. Global Recombinant Proteins Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Global Recombinant Proteins Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Hormones of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Growth Factors of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Cytokines of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Plasma Protein Factor of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Recombinant Metabolic Enzymes of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Immune Checkpoint Regulators of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Others of Recombinant Proteins Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Recombinant Proteins Revenue Share by Company (2024)
 Figure 31. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 32. Hormones Revenue Proportion by Company in 2024
 Figure 33. Growth Factors Revenue Proportion by Company in 2024
 Figure 34. Cytokines Revenue Proportion by Company in 2024
 Figure 35. Plasma Protein Factor Revenue Proportion by Company in 2024
 Figure 36. Recombinant Metabolic Enzymes Revenue Proportion by Company in 2024
 Figure 37. Immune Checkpoint Regulators Revenue Proportion by Company in 2024
 Figure 38. Others Revenue Proportion by Company in 2024
 Figure 39. North America Recombinant Proteins Revenue 2020-2031 (US$ Million)
 Figure 40. North America Recombinant Proteins Revenue Market Share by Type (2020-2025)
 Figure 41. North America Recombinant Proteins Revenue Market Share by Application (2020-2025)
 Figure 42. Asia-Pacific Recombinant Proteins Revenue 2020-2031 (US$ Million)
 Figure 43. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2020-2031)
 Figure 44. Asia-Pacific Recombinant Proteins Revenue Market Share by Type (2020-2025)
 Figure 45. Asia-Pacific Recombinant Proteins Revenue Market Share by Application (2020-2025)
 Figure 46. Europe Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Europe Recombinant Proteins Revenue Market Share by Country (2020-2031)
 Figure 48. Europe Recombinant Proteins Revenue Market Share by Type (2020-2025)
 Figure 49. Europe Recombinant Proteins Revenue Market Share by Application (2020-2025)
 Figure 50. Latin America Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Latin America Recombinant Proteins Revenue Market Share by Country (2020-2031)
 Figure 52. Latin America Recombinant Proteins Revenue Market Share by Type (2020-2025)
 Figure 53. Latin America Recombinant Proteins Revenue Market Share by Application (2020-2025)
 Figure 54. Middle East and Africa Recombinant Proteins Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 55. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Recombinant Proteins Revenue Market Share by Type (2020-2025)
 Figure 57. Middle East and Africa Recombinant Proteins Revenue Market Share by Application (2020-2025)
 Figure 58. Recombinant Proteins Supply Chain (Upstream and Downstream Market)
 Figure 59. Global Production Market Share of Recombinant Proteins Raw Materials by Region in 2024
 Figure 60. Recombinant Proteins Distribution Channels
 Figure 61. Global Recombinant Proteins Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 62. Global Recombinant Proteins Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Gene Recombinant Protein Market Research Report 2024
Global Recombinant Protein Expression System Market Research Report 2024
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Prokaryotic Recombinant Protein Market Research Report 2024
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Collagen for Cosmetics Market Research Report 2024
Global Recombinant Protein Industrial Reagents Market Research Report 2024
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Restructured Collagen for Skin Care Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Recombinant Protein Therapeutics Market
Global Recombinant Antibody Market Research Report 2025
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Global Recombinant Influenza Vaccine Market Research Report 2024
Global Recombinant Protein Biological Research Reagents Market Research Report 2024
Global Prokaryotic Expression System Market Research Report 2025
Protein Expression Vector Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant MAPK Protein Market Research Report 2024
Global Recombinant Trypsin Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions